Barclays lowered the firm’s price target on Haleon (HLN) to 450 GBp from 475 GBp and keeps an Overweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLN:
- Haleon breaks ground on new GBP 130M global oral health center
- Haleon Completes Acquisition of Remaining Stake in China JV
- Haleon Completes First Tranche of Share Buyback Program
- Haleon PLC Executes Share Buyback to Enhance Shareholder Value
- Haleon names Carl Haney as Chief Research & Development Officer